PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer

Published:2017-12 Issue:4 Volume:493 Page:1464-1470
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Lin Xian,Lin Bing-wen,Chen Xiao-li,Zhang Bei-lei,Xiao Xiong-jian,Shi Jing-shi,Lin Jian-dong,Chen Xiao

Funder

Fujian medical university

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference20 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J. Clin.,2017

2. MicroRNA-34a/EGFR axis plays pivotal roles in lung tumorigenesis;Li;Oncogenesis,2017

3. miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis;Song;Biochem. Biophys. Res. Commun.,2017

4. In vivo delivery of miR-34a sensitizes lung tumors to radiation through RAD51 regulation;Cortez;Mol. Ther. Nucleic Acids,2015

5. Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells;Cho;Rna,2016

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA-34 and gastrointestinal cancers: a player with big functions;Cancer Cell International;2024-05-09

2. Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1;Frontiers in Immunology;2024-05-08

3. The microRNA-34 Family and Its Functional Role in Lung Cancer;American Journal of Clinical Oncology;2024-05-03

4. STAT3 eye-opener in COVID-19;Italian Journal of Medicine;2023-11-28

5. LINC00460/miR-143-3p/Serpine1 in Promoting Gastric Cancer (GC) Progression;Journal of Biomaterials and Tissue Engineering;2023-11-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3